Aeglea BioTherapeutics Profit Margin 2015-2021 | AGLE
Current and historical gross margin, operating margin and net profit margin for Aeglea BioTherapeutics (AGLE) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Aeglea BioTherapeutics net profit margin as of June 30, 2021 is 0%.
|Aeglea BioTherapeutics Annual Profit Margins
|Aeglea BioTherapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Aeglea BioTherapeutics, Inc. is a biotechnology company which is engaged in developing enzyme-based therapeutics in the field of amino acid metabolism to treat inborn errors of metabolism and cancer. Its portfolio of products consists of AEB1102, AEB3103, AEB2109 and AEB4104 which are in different clinical trial phase. Aeglea BioTherapeutics, Inc. is based in Austin, Texas.